Moreover, we showed that USP10 knockdown in MES GBM cells resulted in loss of MES properties and decreased tumorigenic ability, while overexpression of RUNX1 reversed the inhibitory effect of USP10 knockdown. The gene discussed is USP10; the disease is glioblastoma.